AYAllison Yan

Allison Yan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Allison Yan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Health‐Related Quality of Life in Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis: A Qualitative Study

    by Jacob McFeeters, Allison Yan, Cole Veliky, Matthew Gallardo, Kelsey Nusbaum, Rachel Kirven, Kristopher Fisher, Abraham Korman, Hyoshin Kim, Benjamin H. Kaffenberger

    Background: Epidermal necrolysis (EN), including Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), are severe cutaneous drug reactions with high morbidity. However, the quality of life (QoL) impact during acute hospitalization is not well understood. Objectives: To explore the acute QoL experience of EN patients and identify key domains to inform future QoL assessment tools and improve care. Methods: Twelve patients with confirmed EN were interviewed using a standardized script. Diagnoses were supported by histopathology and validated scoring systems. Interviews were analyzed thematically using NVivo software. Thematic saturation was reached after nine interviews. Results: Six QoL domains emerged: difficulties with activities of daily living, severe cutaneous symptoms, changes in physical appearance, painful oral symptoms, mental health challenges (e.g., anxiety, low mood), and medical distrust. Trimethoprim‐sulfamethoxazole was the most common culprit drug. All patients received systemic corticosteroids. Conclusions: These findings lay the groundwork for the development and validation of targeted quality‐of‐life assessment tools and support the need for holistic inpatient care strategies tailored to the physical, emotional, and relational disruptions experienced by patients with acute EN.

  • Open Access

    Refined cell transfer model reveals roles for Ascl2 and Cxcr3 in splenic localization of mouse NK cells during virus infection

    by Laura M. Canaday, Andrew Cox, H. Alex Feldman, Harsha Seelamneni, Ayad Ali, Jasmine A. Tuazon, Lorena Botero Calderon, Sierra N. Bennett, Allison Yan, Megan Wilson, et al.

    Cell transfer experiments complement the rigorous investigation of antiviral and antitumor functions of natural killer (NK) cells. Success in these endeavors is enhanced by expansion of small numbers of input NK cells driven by viral antigens or homeostatic proliferation in immunodeficient hosts. In contrast, analysis of other NK-cell functions, including immunoregulation, are non-proliferative and require an intact immune system in recipient mice. We reveal poor persistence of conventional congenic (CD45.1) BoyJ NK cells following adoptive transfer in comparison to CRISPR-generated CD45.1+ (JAXBoy) NK cells. Reciprocal transfers between C57BL/6 and JAXBoy mice substantially improve seeding and maintenance of donor NK cells. Using this system, we confirm that CXCR3 re-positions NK cells in the white pulp of the spleen after infection, which is vital for immunoregulation. Moreover, we discovered that the transcription factor ASCL2 is required for recruitment of NK cells into the spleen and white pulp. These results provide improved tools and novel insights into NK cell biology. Key points JAXBoy are superior to conventional BoyJ mice for NK cell persistence after transfer. CXCR3 repositions donor NK cells in T/B-zones of the spleen after infection. The transcription factor ASCL2 is required for NK-cell recruitment to spleen white pulp.

  • An Assessment of Current Clinician- and Patient-Reported Outcome Measures for Acne Scarring and Dyspigmentation: A Scoping Review

    by James Choe, Rebecca Urbonas, Eric Xia, Allison Yan, Ahana Gaurav, Anne Fladger, John S. Barbieri


  • Impact of morbilliform drug eruptions on health-related quality of life: a qualitative analysis

    by Allison Yan, Matthew Gallardo, Cole Veliky, Jacob McFeeters, Kelsey Nusbaum, Kirsten Johnson, Kristopher Fisher, Abraham Korman, Benjamin Kaffenberger

    Quality of life has not been well-explored in patients hospitalized with morbilliform drug eruptions. We found that morbilliform drug eruptions impacted patients across six major domains: impact on other medical conditions, self-image, medical distrust, impact on diet, mental health and physical symptoms. Dermatologists and other healthcare providers should remain cognizant of the impacted domains in the counselling and management of this patient population.